CeriBell Inc. (CBLL)

19.51

-0.32 (-1.61%)

At close: Mar 28, 2025, 3:59 PM

19.42

-0.44%

After-hours: Mar 28, 2025, 04:59 PM EDT

Company Description

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions.

The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting.

It also offers EEG disposable headbands; and pocket-sized battery-operated recorders.

The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.

The company was incorporated in 2014 and is based in Sunnyvale, California.

CeriBell Inc.

Address: 360 North Pastoria Avenue Sunnyvale, California United States
Website	https://ceribell.com

Name	Position
Dr. Xingjuan Chao Ph.D.	Co-Founder, President, Chief Executive Officer & Director
Dr. Raymond Woo Ph.D.	Chief Technology Officer
Kristie Rodenbush	Chief People Officer
Scott Blumberg	Chief Financial Officer
Brian P. Price	Senior Vice President of Marketing
Dan Rogy	Senior Vice President of Operations
Dr. Josef Parvizi M.D., Ph.D.	Co-Founder, Chief Medical Advisor & Director
Joshua Copp	Chief Business Officer
Louisa Daniels J.D., M.B.A.	General Counsel
Sean Manni	Senior Vice President of Sales